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Abstract
Ocimum basilicum L has been traditionally used for the treatment of inflammatory bowel disease in Iran. This study investigates the
ameliorative effect of Ocimum basilicum essential oil on an acetic acid–induced colitis model in rats. Ocimum basilicum essential oil
with 2 doses (200 and 400 mL/kg) significantly ameliorated wet weight/length ratio of colonic tissue compared to the control
group. Higher doses of essential oil (200 and 400 mL/kg) significantly reduced ulcer severity, ulcer area, and ulcer index. On the
other hand, histological examination revealed the diminution of total colitis index as a marker for inflammatory cell infiltration in
the colonic segments of rats treated with Ocimum basilicum essential oil (200 and 400 mL/kg). The increased level of myeloper-
oxidase was significantly decreased after the treatment with the essential oil (200 and 400 mL/kg). These results suggest that
Ocimum basilicum exhibits protective effect against acetic acid–induced colitis.
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Inflammatory bowel diseases (IBDs), including ulcerative colitis
and Crohn’s disease, are immune-mediated chronic relapsing
intestinal disorders characterized by the presence of the chronic
inflammatory process of the bowel. Although the etiopathogenesis
of IBD remains unclear, the current literature suggests that genetic,
microbial, environmental, and immune factors contribute to the
disease.1 The main physical symptoms include abdominal pain,
diarrhea, mucous, bloody stools, and psychosocial consequences
such as loss of control, energy, feeling a burden, isolation, and
fear.2,3 The pathological characteristics of ulcerative colitis consist
of transmural inflammation of neutrophils,macrophages, and lym-
phocytes, ultimately leading to nonspecific intestinal inflamma-
tion.4 Moreover, it has been proposed that the inflammatory
cascade in the pathological process of colitis results from the
overexpression of pro-inflammatory mediators such as cyto-
kines, eicosaniods, reactive oxygen species, and neutrophil
infiltration.5 Available current therapy for IBD including cor-
ticosteroids, 5-aminosalicylates, and immunosuppressants, is
not entirely effective and both short-term and long-term
adverse effects confine their use.6 Nowadays, there is an
increasing interest for traditional, complementary and alterna-
tive medicines.7 It may have originated from their easy acces-
sibility, lower costs, and possibly their lower adverse effects.8
Traditional Persianmedicine as one of themost ancient schools
is a welcomed system in Iran.9,10 Ocimum basilicum has been
mentioned in different traditional Persian medicine resources
such asAvicenna (980-1037AD)Canon ofMedicine for a vari-
ety of diseases.11,12 In addition, Aghili Shirazi, in his famous
book, The Storehouse of Medicaments, which was written
about 1772 AD, has recommended it for symptoms presenting
in ulcerative colitis.13,14 In recent decades, medicinal plants
have been used as an important source for the search of new
compounds with anti-inflammatory potential.15 Ocimum basi-
licum L (Lamiaceae), popularly known as basil, is a culinary
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plant extensively utilized as a flavoring agent and has been
applied for the treatment of gastrointestinal disorders including
diarrhea, vomiting, gastrodynia, dyspepsia, flatulence, and gastri-
tis.16,17 Relevant studies have identified anti-inflammatory, anti-
oxidant, antiulcerogenic, immunomodulatory, antitumor,
antibacterial, antiviral, and antifungal activities of the Ocimum
genus.16,18-24 Sajjadi demonstrated 20 compounds of essential oil
being obtained from Ocimum basilicum cultivated in Isfahan,
Iran, namely methyl-chavicol (52.4%), linalool (20.1%),
epi-a-cadinol (5.9%), and trans-a-bergamotene (5.2%).25 In
addition, it has been shown that natural monoterpenes act as
anti-inflammatory drugs.26 Hence, the present study aimed to
assess the anti-inflammatory potential of Ocimum basilicum
essential oil as a source of monoterpenes in the rat model of
acetic acid–induced colitis. We have investigated the inflam-
matory response by macroscopic and histopathological analy-
sis as well as the determination of myeloperoxidase as an
inflammation marker.
Methods
Plant Material and Preparation of Essential Oil
The aerial parts of the plant were collected from Najwan district, Isfa-
han, Iran. A voucher specimen (No. RD-112) was deposited by Dr
Ghannadi, a plant taxonomist at the Herbarium of Faculty of Phar-
macy and Pharmaceutical Sciences, Isfahan University of Medical
Sciences, Isfahan, Iran. The essential oil was prepared by hydrodistil-
lation of the air-dried, powdered, aerial parts of the plant for 3 hours
according to the method recommended in European Pharmacopoeia.27
Analysis of the Essential Oil
The essential oil was analyzed by gas chromatography–mass spectro-
metry (GC/MS) on a Hewlett Packard 6890 MS selective detector
coupled with Hewlett Packard 6890 gas chromatograph equipped with
a cross-linked 5% PHME siloxane HP-5MS capillary column (30 m
0.25 mm; film thickness 0.25 mm) operated under the same conditions
as follows: carrier gas, helium with a flow rate of 2 mL/min; column
temperature, 60C to 275C at 4C/min; injector and detector tem-
perature, 280C; volume injected, 0.1 mL of the oil; split ratio, 1:50.
The MS operating parameters were as follows: ionization potential
70 eV, ionization current 2 A, ion source temperature 200C, resolu-
tion 1000. The identification of oil components was based on the com-
puter matching with the Wiley 275L library as well as comparison of
the fragmentation patterns of mass spectra with those reported in the
literature.28-30 The relative percentage of the oil constituents was cal-
culated from peak areas.
Animals
Thirty-six male Wistar rats (180-220 g) acquired from the animal
house of the School of Pharmacy, Isfahan University of Medical
Sciences, Isfahan, Iran, were used in this study. Animals were main-
tained at controlled environmental conditions where the temperature
was maintained at 20C to 23C, relative humidity at 50% to 60%, with
a 12:12 hour light/dark cycle. All animals were given access to a stan-
dard pellet diet andwater ad libitum. Animals were housed individually
in standard cages and acclimatized for 7 days before the initiation of the
treatment. The animal study was approved by the guideline of the Ethi-
cal Committee of Isfahan University of Medical Sciences.
Chemicals
Dexamethasone was purchased from Iran Hormone Pharmaceutical
Company (Tehran, Iran). Hexadecyl trimethyl-ammonium bromide
(HTAB) and O-dianisidine dihydrochloride were purchased from
Sigma Chemical Co (St Louis, MO). Formalin solution 35% w/w, gla-
cial acetic acid, and diethyl ether oxide were purchased form Merck
(Darmstadt, Germany). All other solvents and chemicals were of ana-
lytical grade. Test samples including the suspension of reference drug
and the emulsion of Ocimum basilicum essential oil were freshly pre-
pared using 0.2% Tween 80 in normal saline as a vehicle for oral (po)
administration.
Animal Groups
Animals were randomly divided into following groups of 6 rats in
each: sham group, received normal saline (1 mL, po) without induc-
tion of colitis; control group, received vehicle (1 mL, 0.2% Tween
80, po) 2 hours before induction of colitis; dexamethasone group, dex-
amethasone (2 mg/kg, po) was given 2 hours prior to induction of coli-
tis. Test groups received Ocimum basilicum essential oil at doses of
(100, 200, 400 mL/kg, po) 2 hours before induction of colitis. All treat-
ments were performed for the following 5 days. The test plant samples
were freshly prepared prior to administration.
Induction of Experimental Colitis
The animals were fasted for 24 hours with free access to water
before the induction of colitis. Acute colitis was induced using a
modification of the method described by Mascolo et al.31 The rats
were lightly anesthetized with diethyl ether, and a flexible plastic
catheter was inserted into the anus up to a length of 8 cm, and then
2 mL of acetic acid (4% v/v in 0.9% saline) was slowly infused. The
rats were then maintained in a head down position for 1 minute to
prevent solution leakage.
Evaluation of Colon Macroscopic Damage
The rats were killed 24 hours after the last treatment (day 6) by an
overdose of ether inhalation. The last 8 cm of the colon was excised,
opened longitudinally, rinsed with normal saline, and the wet weight
was measured.32 Then the tissue specimens of colon were used for
macroscopic scoring and histopathology damage and the measurement
of tissue myeloperoxidase activity. Macroscopic damage appearance
was scored by an independent observer according to the following
scale: 0 ¼ no macroscopic changes; 1 ¼ mucosal erythema only;
2 ¼ mild mucosal edema, slight bleeding, or slight erosion; 3 ¼ mod-
erate edema, bleeding ulcers, or erosions; and 4 ¼ severe ulceration,
erosions, edema, and tissue necrosis.33 Tissue specimens were cut into
2 pieces, one piece for histopathology assessment (maintained in 5 mL
formalin 10% as fixator) and the other for measuring myeloperoxidase
enzyme activity. The pieces for measuring the myeloperoxidase
enzyme activity were frozen in liquid nitrogen and kept in a freezer
(70C). Furthermore, ulcer area was assessed by Fiji-Win 32 soft-
ware (NIH Image for the Macintosh, 2004). For each specimen, ulcer
index was measured with summing ulcer score and ulcer area using the
following formula: Ulcer index ¼ Ulcer area (cm2) þ Macroscopic
damage score.34
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Assessment of Colon Histopathological Damage
Colon tissues were separately fixed in 10% formalin, dehydrated,
paraffin embedded, processed, sectioned as 4-mm-thick sections,
deparaffinized with xylene, hydrated, and stained with hematoxylin
and eosin. Inflammation severity (0 ¼ none, 1 ¼ slight, 2 ¼ moder-
ate, 3 ¼ severe), extent (0 ¼ none, 1 ¼mucosa, 2 ¼mucosa and sub-
mucosa, 3 ¼ transmural), as well as crypt damage (0 ¼ none, 1 ¼
basal 1/3 damaged, 2 ¼ basal 2/3 damaged, 3 ¼ surface epithelium
intact only) were assessed in hematoxylin and eosin–stained, coded
sections using a modification of a validated scoring scheme
described by Cooper et al35 and Dieleman et al.36 Total colitis index
was measured by summing the scores of inflammation severity,
inflammation extent, and crypt damage. Histological damages were
investigated using a Zeiss microscope equipped with a Sony color
video camera for digital imaging.
Determination of Myeloperoxidase Activity
Tissue myeloperoxidase activity was measured according to the
method described by Bradley et al37 with some modifications. A por-
tion of colon tissue (0.1 g) was homogenized in 1 mL of 50 mM potas-
sium phosphate (pH 6) with 0.5% HTAB in an ice bath using a
polytron homogenizer. More buffers were added to obtain a concen-
tration equivalent to 5 mL per 0.1 g of colon tissue. The resultant
homogenate was sonicated in an ice bath for 10 seconds, then sub-
jected to a sequence of freezing and thawing for 3 times, sonicated
again for 10 seconds and centrifuged for 15 minutes at 15 000 rpm
at 4C. A total of 0.1 mL of the supernatant was mixed with 2.9 mL
of 50 mM phosphate buffer (pH 6) containing 0.167 mg/mL
O-dianisidine dihydrochloride and 0.0005% hydrogen peroxide. The
change in absorbance at 460 nm was measured using a UV/VIS spec-
trophotometer (LSI Model Alfa-1502). Myeloperoxidase activity was
reported as units (U) per gram (g) weight of wet colon tissue.
Statistical Analysis
The results are reported as mean + SEM or median (range). All
statistical analyses were performed using GraphPad Prism 5.0 soft-
ware. Group differences were calculated by parametric one-way
analysis of variance with Tukey’s HSD as post hoc test. Nonpara-
metric data were analyzed using Kruskal-Wallis followed by
Mann-Whitney U test. For all tests, differences with values of P <
.05 were considered significant.
Results
Analysis of the Essential Oil
Thirty-two constituents were characterized accounting for
90.91% of total oil components detected, which are listed in
Table 1 with their percentage composition and retention
indices. The principal constituents of Ocimum basilicum
essential oil was linalool (39.73%), followed by b-pinene
(6.65%), trans-verbenol (6.39%), and a-terpinolene (5.03%).
Macroscopic Results
No mortality was observed in animals receiving intracolonic
4% acetic acid (2 mL) solution. Acetic acid caused severe
ulceration and hemorrhage of colonic mucosa in control group
(Table 2 and Figure 1B); dexamethasone significantly reduced
macroscopic damage score, ulcer area, ulcer index, and weight/
length ratio of distal colon (8 cm) compared to the control
group (P < .001; Table 2 and Figure 1C). On the other hand,
Ocimum basilicum essential oil (200 and 400 mL/kg) showed
significant decrease in macroscopic damage, ulcer area, ulcer
index, and weight/length ratio of distal colon compared to the
control group (P < .001; Table 2, Figure 1E and F). In addition,
treatment with 100 mL/kg dose of Ocimum basilicum essential
oil was not effective to reduce weight/length ratio as well as
ulcer index (ulcer area þ ulcer severity) in colon samples com-
pared to control group (Table 2 and Figure 1D). No significant
differences were found between dexamethasone and Ocimum
basilicum essential oil (200 and 400 mL/kg) groups (P > .05).
Microscopic Results
In the sham group, histological evaluation of the colon mucosa
showed no inflammation or necrosis (Table 3 and Figure 2A).
On the other hand, acetic acid–induced colitis displayed
destruction of epithelium, transmural necrosis, edema, areas
of hemorrhage, and submucosal inflammatory cellular
Table 1. Volatile Constituents of the Essential Oil of Ocimum
Basilicum.
Number Compound Percentage Retention Index
1 Linalool 39.37 1099
2 b-Pinene 6.65 978
3 Trans-verbrnol 6.39 1146
4 a-Terpinolene 5.03 1089
5 Limonene 3.03 1030
6 Verbenone 2.41 1205
7 Pinocarveol 2.33 1138
8 Camphene 2.31 951
9 Longifolene 2.15 1406
10 Bornyl acetate 1.84 1288
11 d-3-Carene 1.72 1010
12 Cis-Verbenol 1.65 11.41
13 Sabinene 1.57 974
14 a-Terpineol 1.53 1191
15 Trans-b-ocimene 1.48 1041
16 Thymol 1.47 1293
17 b-Myrcene 1.18 990
18 1,8-Cineole 1.17 1032
19 r-Cymene 1.14 1025
20 Terpinene-4-ol 0.97 1179
21 Myrtenol 0.94 1196
22 a-Pinene 0.73 937
23 Trans-carveol 0.67 1219
24 Germacrene-D 0.61 1487
25 Tricyclene 0.58 924
26 a-Terpinene 0.53 1019
27 b-Eudesmol 0.35 1659
28 a-Phellanderene 0.31 1003
29 Terpinene 0.15 1060
30 Cis-calamene 0.11 1538
31 Hexanal 0.10 801
32 b-Caryophyllene 0.10 1422
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infiltration (Table 3 and Figure 2B). Dexamethasone (2 mg/kg)
and Ocimum basilicum essential oil at doses (200 and 400
mL/kg) showed significant reduction of neutrophil infiltration,
edema, and extent or severity of tissue damage, as evaluated
by total colitis index (Table 2 and Figure 2C, D, and E, respec-
tively; P < .001).
Myeloperoxidase Activity
Intrarectal administration of acetic acid caused significant
increase in the level of myeloperoxidase in colonic tissue when
compared to the sham group (P < .001). In contrast, myeloper-
oxidase activity was decreased (P < .001) in groups treated
with Ocimum basilicum essential oil (200 and 400 mL/kg) as
well as dexamethasone (2 mg/kg) (Figure 3).
Discussion
The present study demonstrates thatOcimum basilicum essen-
tial oil reduces tissue damage in experimental model of acetic
acid–induced colitis as established by macroscopic, histologi-
cal, and biochemical changes. The anti-inflammatory effects
of this substance observed in this study is in accordance with
previous investigations of its ability to prevent carrageenan-
induced paw edema and turpentine oil–induced acute inflam-
mation in rats.18,38 Intrarectal administration of acetic acid is
one of the validated methods to induce an experimental model
of IBD. This method is widely adopted to screen potential
drugs due to its similarity to human IBD. Destruction of
mucosal barrier and colon structure by chemical stimulation,
enhanced vasopermeability, and increased inflammatory
Figure 1.Macroscopic photographs of colon tissue 5 days after acetic acid–induced colitis in rats: (A) sham group treated with saline; (B) colitis
in control group treated with vehicle; (C) colitis in dexamethasone-treated group; (D, E, and F) Colitis in Ocimum basilicum essential oil–treated
group, 100, 200, and 400 mL/kg, respectively.
Table 2. Effects of Ocimum basilicum Essential Oil on the Macroscopic Parameters of Colitis Induced by Acetic Acid in Rats.a
Groups N Ulcer Score Ulcer Area (cm2) Ulcer Index Weight/Length Ratio
Sham (saline) 6 0.00 + 0.00 0.00 + 0.00 0.00 + 0.00 87.80 + 4.35
Control (vehicle) 6 3.60 + 0.25 6.10 + 0.30 9.70 + 0.30 235.0 + 6.80
Dexamethasone (2 mg/kg) 6 1.40 + 0.25* 1.30 + 0.20* 2.70 + 0.45* 133.80 + 6.65*
Essential oil, low dose (100 mL/kg) 6 2.80 + 0.20 5.10 + 0.40 7.90 + 0.60 231.6 + 4.95
Essential oil, medium dose (200 mL/kg) 6 1.80 + 0.21* 3.20 + 0.40* 5.00 + 0.61* 181.2 + 5.49*
Essential oil, high dose (400 mL/kg) 6 1.60 + 0.25* 1.70 + 0.30* 3.30 + 0.55* 148.2 + 5.25*
aData are expressed as mean + SEM.
*P < .001, indicates significant difference versus control.
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mediators are major contributing factors in the induction of
this animal model.39-41 The decrease in the wet weight of
the inflamed colon tissue can be directly correlated with the
severity and extent of inflammation.42 Our finding showed
that treatment with essential oil could reduce the wet
weight/length ratio of distal colon segments and macroscopic
damage score compared with colitis control group. In addi-
tion, tested substances significantly decreased the histological
signs of inflammation such as infiltration of lymphocytes and
macrophages into the mucosa, edema, and tissue damage.
Neutrophil accumulation in the inflamed colonic mucosa is
one of the most noticeable histopathological aspects of IBD.
Myeloperoxidase is a proteolytic heme enzyme existing in
neutrophil granulocytes that combat against bacteria. These
enzymes are released from activated neutrophils and catalyze
the formation of hypochlorous acid from hydrogen peroxide
and chloride ions that lead to the oxidative injury associated
with induction of colitis.41,43 The activity of myeloperoxidase
from the damaged tissue is directly proportional to the number
of neutrophils observed in histological fields.44 Therefore, the
reduction in the activity of myeloperoxidase can be explained
as a manifestation of the anti-inflammatory effect of a given
Table 3. Effects of Ocimum basilicum Essential Oil on the Microscopic Parameters of Colitis Induced by Acetic Acid in Rats.a
Groups N
Inflammation
Severity (0-3)
Inflammation
Extent (0-3)
Crypt
Damage (0-4)
Total Colitis
Index (0-10)
Sham (saline) 6 0 0 0 0
Control (vehicle) 6 3 (3) 3 (3) 4 (4) 10 (10)
Dexamethasone (2 mg/kg) 6 1 (1)* 1 (1-2)* 1 (0-1)* 3 (2-4)*
Essential oil, low dose (100 mL/kg) 6 3 (2-3) 2.5 (2-3) 3.5 (3-4) 9 (7-10)
Essential oil, medium dose (200 mL/kg) 6 1.5 (1-2)* 2 (1-3)* 2 (2-3)* 5.5 (4-8)*
Essential oil, high dose (400 mL/kg) 6 1 (1-2)* 1.5 (1-2)* 1 (0-2)* 3.5 (2-6)*
aData are expressed as median (range).
*P < .001, indicates significant difference versus control (Mann-Whitney U test).
Figure 2. Microscopic presentation of acetic acid–induced colitis in rats stained by hematoxylin and eosin (light microscopy, 20): (A)
normal colon treated with saline, mucus layer, and crypts are normal and leucocyte infiltration is absent; (B) colitis in control group
treated with vehicle, mucosal and submucosal inflammation, as well as crypt damage and leucocyte infiltration are evident (arrow);
(C) dexamethasone-treated colitis; (D) Ocimum basilicum essential oil (200 mL/kg) treated colitis; (E) Ocimum basilicum essential oil
(400 mL/kg) treated colitis.
Figure 3. Effect of Ocimum basilicum essential oil (100, 200, and 400
mL/kg) on myeloperoxidase (MPO) enzyme activity in the colonic tis-
sue. Dexa ¼ dexamethasone. Results are presented as mean + SEM
(N ¼ 6). ***P < .001 compared to control, one-way analysis of var-
iance followed by Tukey test.
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drug. Our research showed that the administration of Ocimum
basilicum essential oil decreased the myeloperoxidase level
during acetic acid–induced colitis indicating an excellent
anti-inflammatory activity on experimental colitis model.
Phytochemical composition analysis indicated that Ocimum
basilicum essential oil possessed compounds such as linalool,
cis-verbenol, b-pinene, and a-terpinolene.
Cis-verbenol, one of the active constituents present in
Ocimum basilicum essential oil, has been shown to have anti-
inflammatory activity by the reduction of the expression levels
of pro-inflammatory cytokines in ischemic brain and immunos-
timulated glial cells.45 Another compound linalool has been
shown to exhibit protective effect against lipopolysaccharide
(LPS)/D-galactosamine (GalN)-induced liver injury in mice
through inhibition of caspase-3 and caspase-8 expression and
the reduction of inflammatory response via NF-kB suppres-
sion.46 Linalool has been reported to reduce LPS-induced
tumor necrosis factor-a and interleukin-6 production both in
vitro and in vivo, block phosphorylation of IkBa protein,
p38, c-Jun terminal kinase, and extracellular signal-regulated
kinase in LPS-stimulated RAW 264.7 cells and could attenuate
histological changes in lipopolysaccharide-induced lung
injury mouse model.47 Deepa and Venkatraman Anuradha48
had shown that linalool could be useful for the treatment of
renal damage in diabetic subjects through the attenuation of
TGF-b1 and NF-kB expression.
In conclusion, the present study showed that Ocimum basi-
licum essential oil could inhibit acetic acid–induced colitis in
rats by reducing leukocytes accumulation and inhibiting mye-
loperoxidase production. This anti-inflammatory effect may,
at least in part, be due to the presence of monoterpenes, which
are known to inhibit the inflammatory signaling through
NF-kB suppression.26 The results of this study show that Oci-
mum basilicum essential oil could potentially be useful as a
supplemental remedy for the treatment of IBD. However, fur-
ther investigations are needed to elucidate the entire mechanism
of action ofOcimum basilicum essential oil and its isolated com-
pounds on the cell receptors and signaling pathways associated
with colitis.
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